Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating oral etrasimod for adults with moderately to severely active Crohn's disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Etrasimod (etrasimod)

Snippet

Sponsor: Pfizer | Conditions: Crohn's Disease | Phase 3 | Status: TERMINATED